Search Results for πŸ’—πŸ˜ΉπŸ’€ Viagra 200mg - sildenafil citrate without prescription 🐯 www.USPharm.ORG πŸ―πŸ• ↩. cheap online pharmacyπŸ’šβœ“βœ…:Order Sildenafil Citrate (Viagra) Pills, High dose sildenafil citrate as a salvage therapy for - PubMed,High dose sildenafil citrate as a salvage therapy for - Nature

News roundup: Now Clover Health faces delisting; BlackCat/ALPHV affiliate with 4TB of data puts it up for sale; $58M for Biolinq’s ‘smallest blood glucose biosensor’

...considered a reverse stock split to be approved by shareholders but the share price improved on its own and the action was not necessary. This year, it may be. Clover is currently trading at $0.7365. Last August, it hit a high of $1.55 before sliding to below $1.00. An example of a SPAC through Social Capital Hedosophia Holdings, it hit a high of over $15 on 8 January 2021 before cracking that year based on revelations that Clover did not reveal a Department of Justice investigation starting the prior year, which prompted an SEC investigation [TTA 9 Feb 2021], triggering... Continue Reading

News roundup: Amwell faces NYSE delisting; Walmart Health slows Health Centers, except Texas; Novosound’s ultrasound patent; Eko’s Low EF AI; Universal Brain; Elizabeth Holmes in ‘Dropout’ + update

...high-resolution sensors to be integrated into other wearables such as smartwatches and other monitors. Novosound’s patent covers both the US and UK. In 2022, they inked a commercial partnership with diagnostics and digital health company PAVmed Inc. for intravascular imaging. Novosound was the first spinoff from the University of the West of Scotland. Mobihealthnews Also in cardiac, the FDA cleared Eko Health’s Low EF detection AI. This enables a provider to quickly diagnose Low EF (ejection fraction) in a physical exam to assess possible heart failure. The Eko stethoscope and module connects to a tablet and provides a reading within... Continue Reading

Teladoc CEO Jason Gorevic steps down immediately in shock announcement

...Gorevic’s departure after 15 years due to Teladoc’s lackluster 2023 and a dismal forecast for 2024. Teladoc never really recovered from a disastrous 2020 $18.5 billion acquisition of Livongo engineered by Mr. Gorevic with Glen Tullman, followed by its 2022 $6.6 billion writedown. The share price never really recovered, reaching a high over $293 in February 2021 but eroding quickly after that. It currently languishes at below $15, losing 34% YTD and 95% since 2021. The crash in Teladoc’s value as the pandemic closures of practices resolved was replicated by other telehealth companies such as Amwell, MDLIVE, Included, and most... Continue Reading

ATA requests expediting of revised proposed rule on controlled substance telehealth prescribing; announces Nexus 2024 meeting 5-7 May

...Schedule II–V controlled medications via audio-video telemedicine encounters, including Schedule III–V narcotic controlled medications approved by the Food and Drug Administration (FDA) for maintenance and withdrawal management treatment of opioid use disorder. ATA release HealthcareDive 4 April ATA is also resuming an in-person spring conference, Nexus 2024, 5-7 May, at the Phoenix Convention Center in Arizona. It will have 300 speakers on 30+ topics. The meeting is being pitched to primarily care delivery and provider organizations. An overview of the conference is in the ATA release. More content information here (PDF link). Online registration (attendee and exhibitor) or email AmericanTelemedicine@​xpressreg.net... Continue Reading

Davids (AliveCor, Masimo) v. Goliath (Apple): the patent infringement game *not* over; Masimo’s messy proxy fight with Politan (updated)

...on patent infringement on his atrial fibrillation app (2021), also involving the USPTO, an action that is wending its way through courts now. While this Editor has long been mystified by Apple’s continued combativeness against small innovative companies when certainly it would be cheaper (and more respectful) to pay a license or settlement, FTA in MedCityNews citing Dr. Wiesel’s attorney Andrew Bochner, “Apple is known among the legal community to have a certain modus operandi: they do “not entertain any sort of real settlement discussions” and instead battle “tooth and nail” in order to wear out their rivals with fewer... Continue Reading

Perspectives: Working with a PR Agency–How to Make the Most of the Partnership

...enthusiasm and high hopes. Without a clear focus and realistic objectives, the relationship may never produce the anticipated benefits for either party. To that end, here are some important tips on what clients should do to maximize return on investment and reach the strategic goals of their public relations partnerships. It’s all about alignment: At the beginning of the engagement, ensure that both client and agency are fully aligned on goals and key performance indicators (KPIs). Specifically, those KPIs need to help the client accomplish its goals, not the agency’s. Think long- and short-term from the beginning: Agencies can produce... Continue Reading

Mid-week news roundup: US offers $10M for BlackCat/ALPHV info; most Change systems still down; Risant closes Geisinger buy; SureScripts exploring sale; DarioHealth 2023 revenue -23%; Amazon Pharmacy same-day delivery NYC and LA

...this Editor noted then, it was a feat of funding legerdemain that rivaled a Frank Lorenzo deregulation-era airline acquisition. Their information around 2023 earnings isn’t much different. Dario provides a combined app and in-person approach to musculoskeletal (MSK) therapy, diabetes (including GLP-1 drugs), hypertension, weight management, and behavioral health. Mobihealthnews, Dario release And speaking of pharmacy, Amazon Pharmacy expanded same-day medication-delivery offerings to NYC residents and the greater Los Angeles area. This adds to same-day prescription delivery available in Phoenix, Austin, Seattle, Indianapolis, Miami, and Texas, including free drone delivery in College Station. How it works: Amazon has small facilities... Continue Reading

Short takes: PocketHealth, Brightside fundings; VA OIG reports hit Oracle Cerner; Change cyberattack/legal updates; UHG-Amedisys reviewed in Oregon; Optum to buy Steward Health practices

...programs for psychiatry, therapy, and their Crisis Care program for individuals with elevated suicide risk. Release The Department of Veterans Affairs Office of Inspector General (OIG) released three reports last Thursday (20-21 March) that were sharply critical of the new Oracle Cerner EHR. While Oracle Cerner Millenium operates in only five VA locations, not including the joint MHS/Genesis Lovell FHCC, each one has been problematic from training to implementation–and are on hold. The OIG reports available here on the Electronic Health Records Modernization (EHRM) are scathing on the EHR’s scheduling and pharmacy features leading to patient safety and staff usability... Continue Reading

Can digital health RPM achieve meaningful change with type 2 diabetics? New metastudy expresses doubt.

...is the worth? The PHTI study recommended that: Payers use these solutions for the highest risk and diverse/underserved populations Regularly analyzing outcomes and tie contracts to clinical performance Focus on patients with higher starting HbA1c newly starting insulin Payers could also recommend nutritional ketosis as the Virta program had greater benefits. Solutions could also evolve to include GLP-1 drugs, CGMs, and nutritional ketosis. PHTI study (free download of full report, four sections, and appendices). PHTI press release. PHTI is also offering a free webinar on Thursday 28 March at 2pm US Eastern Time on assessing digital diabetes management tools–registration here.... Continue Reading

2023 US data breaches topped 171M records, up 187% versus 2022: Protenus Breach Barometer

2023’s US healthcare data breaches hit an all time high, both in reported breaches and number of records affected. Protenus, which publishes an annual Breach Barometer, uses multiple data sources including Health and Human Services’ public breach tool. The numbers are shocking for both: HHS 2023 reported 725 reports and about 135 million records Protenus‘ numbers are significantly higher: 1,161 reports and 171,139,241 breached records. In 2022, the totals were respectively 1,138 reports affecting a total of 59,664,152 breached records. Breached records were up 187% in 2023. The variance in reporting is due to factors including not knowing the true... Continue Reading